Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation

Sara Carvalho, Esther G. C. Troost, Judith Bons, Paul Menheere, Philippe Lambin, Cary Oberije

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)487-494
JournalRadiotherapy and Oncology
Volume119
Issue number3
DOIs
Publication statusPublished - Jun 2016

Keywords

  • Prognostic model
  • Blood-biomarkers
  • NSCLC

Cite this